Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development.
about
Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cellsXanthorrhizol: a review of its pharmacological activities and anticancer propertiesAntibody-drug conjugates as novel anti-cancer chemotherapeuticsFOLFOX/FOLFIRI pharmacogenetics: the call for a personalized approach in colorectal cancer therapyNew insights in bilirubin metabolism and their clinical implicationsThe role of drug transporters in the kidney: lessons from tenofovirpH Dependent but not P-gp Dependent Bidirectional Transport Study of S-propranolol: The Importance of Passive DiffusionCyclooxygenase-2 and cancer treatment: understanding the risk should be worth the rewardSchisandra chinensis regulates drug metabolizing enzymes and drug transporters via activation of Nrf2-mediated signaling pathwayMRP2 and the handling of mercuric ions in rats exposed acutely to inorganic and organic species of mercuryRelationships between the renal handling of DMPS and DMSA and the renal handling of mercuryPopulation pharmacokinetics of oral baclofen in pediatric patients with cerebral palsyVascular pathology of medial arterial calcifications in NT5E deficiency: implications for the role of adenosine in pseudoxanthoma elasticumGlutathione status and the renal elimination of inorganic mercury in the Mrp2(-/-) mouse.Modulation of a Schistosoma mansoni multidrug transporter by the antischistosomal drug praziquantel.Montelukast is a potent and durable inhibitor of multidrug resistance protein 2-mediated efflux of taxol and saquinavirTissue-specific transcript profiling for ABC transporters in the sequestering larvae of the phytophagous leaf beetle Chrysomela populiXenobiotic, bile acid, and cholesterol transporters: function and regulation.Micellar electrokinetic chromatographic analysis for in vitro accumulation of anthracyclines enhanced by inhibitors of cell membrane transporter-proteins in cancer cells.The synthesis and characterization of cellular membrane affinity chromatography columns for the study of human multidrug resistant proteins MRP1, MRP2 and human breast cancer resistant protein BCRP using membranes obtained from Spodoptera frugiperdaDrug-Resistant Epilepsy: Multiple Hypotheses, Few AnswersChemosensitizing indomethacin-conjugated dextran-based micelles for effective delivery of paclitaxel in resistant breast cancer therapy.The role of shear stress in Blood-Brain Barrier endothelial physiologyKaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc.Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 yearsABCC11/MRP8 Expression in the Gastrointestinal Tract and a Novel Role for Pepsinogen Secretion.MicroRNA signatures in chemotherapy resistant esophageal cancer cell lines.Aryl hydrocarbon receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier.Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation.Alteration of hepatic but not renal transporter expression in diet-induced obese miceA microdosing approach for characterizing formation and repair of carboplatin-DNA monoadducts and chemoresistance.Structurally distinct ligands rescue biogenesis defects of the KATP channel complex via a converging mechanism.The epothilones: new therapeutic agents for castration-resistant prostate cancer.Regulation of hepatic ABCC transporters by xenobiotics and in disease states.Programmed reduction of ABC transporter activity in sea urchin germline progenitorsIn vitro blood-brain barrier models: current and perspective technologiesImpact of terminal dimethylation on the resistance profile of α-N-heterocyclic thiosemicarbazonesUpregulation of Multidrug Resistance-Associated Protein 1 by Allyl Isothiocyanate in Human Bronchial Epithelial Cell: Involvement of c-Jun N-Terminal Kinase Signaling Pathway.Targeting of BRAF resistant melanoma via extracellular matrix metalloproteinase inducer receptorIntracellular accumulation of Praziquantel in T lymphoblastoid cell lines, CEM (parental) and CEMVBL(P-gp-overexpressing).
P2860
Q24628715-DDCAFDEC-5D3B-4F96-9DB1-3A599D30CDA0Q26779343-8A0A5A90-AE88-4703-AC66-D68C9D13A35BQ26800175-D5664C22-CB11-4EA8-A869-82F23247D5E8Q26851060-1C801E0C-0768-4FF2-89ED-8B8526133A97Q26863145-D941B2B8-E114-438A-B275-D4A5547E71E7Q26866489-D1162283-4E46-4FBF-B5C2-BC6395BBA537Q27314887-D3932147-FB55-4801-8F43-7BF9EB225498Q28274081-BE7D4C35-DC93-4190-9FF8-45D3C25B4568Q28385056-2DD73203-87CA-41BD-9223-B9D984E6243EQ28566844-A078247F-8F88-45F4-A8D3-3E759D3D6919Q28607601-D4D8FAF0-28F3-4046-B458-902539A2C966Q30405534-2A6BECD3-3BF2-44A6-9FD9-F23DC9AEA2F1Q30499841-7E3072F6-453C-4BD9-8CFB-DBB5FD9FB2A1Q31139351-E7CDDE25-D6B5-4A7B-8B0B-16900E76541CQ33552868-5638EB41-5097-4278-9D76-12A77FD039EAQ33611816-E322123C-3D5D-40B1-A34A-C00C21D51B89Q33699994-DA1CBAAA-CA5B-4490-A5E7-B1405A3178D4Q33714593-4E255F74-60CE-4B28-82EA-6B0009337964Q33795090-203798F8-C528-48BF-A572-2CF325E95430Q33833252-46860D84-F45F-45E4-925F-45DAFD8E2B4FQ33875271-AAE04409-A5E6-4264-A972-E06E92283CE6Q33883851-59170141-5914-4B2C-A799-25DC6CDBBEE6Q33898503-016A4FD2-3C85-4E15-B9CB-F022C0612A39Q33914646-8502D7E3-9E97-4492-B504-27EDF3B58416Q34008793-2612273A-726B-403B-B446-62502060559BQ34184465-A33ADECE-21AA-43C3-B607-97575222BC0CQ34405157-FC223601-5CEE-4797-A01D-6A884E944310Q34502705-BFB9EBB1-CC2F-4B24-BCCA-53DA26BCEC8EQ34606100-96D63EE2-4788-46D6-A083-14DFC6FD8329Q35002476-428892C2-8AF3-4A0E-8FFE-36F9E5689D6DQ35131936-9DDEA2FD-3FAC-48D0-9A40-468576BA86E2Q35199497-26323EFB-D3D7-439F-A874-5F3627922F76Q35584399-F16860EE-325B-4FB2-AF72-E503C6541F52Q35690177-7AD17674-503C-4F4B-886D-50EC93B30C77Q35691603-9BF01F43-67F7-482F-881E-1D120072EF72Q35782792-5A12A930-2FB3-4D95-8DF3-AA9D0279D109Q35928856-DAB3E893-9527-4BB8-BC42-6CABE66FA2ADQ35932497-347A2465-1B3F-44B6-9841-269DD5AC4E47Q36078281-C9DCB9D7-2570-4BA0-BC62-65F2CFE543A9Q36103626-23E14A1C-177C-4F20-9603-53E7EDC8060D
P2860
Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Substrates and inhibitors of h ...... lications in drug development.
@en
Substrates and inhibitors of h ...... lications in drug development.
@nl
type
label
Substrates and inhibitors of h ...... lications in drug development.
@en
Substrates and inhibitors of h ...... lications in drug development.
@nl
prefLabel
Substrates and inhibitors of h ...... lications in drug development.
@en
Substrates and inhibitors of h ...... lications in drug development.
@nl
P2093
P1476
Substrates and inhibitors of h ...... lications in drug development.
@en
P2093
Chun Guang Li
Lin-Lin Wang
Shu-Feng Zhou
Yuan Ming Di
P304
P356
10.2174/092986708785132870
P50
P577
2008-01-01T00:00:00Z